Preliminary report of the safety and efficacy of gemtuzumab ozogamicin (Mylotarg (R)) given in combination with cytarabine and daunorubicin in patients with acute myeloid leukemia

DeAngelo, D., Russo, D., Castaigne, S., Esteve, J., Burnett, Alan Kenneth, Goldstone, A., Tallman, M., Bradstock, K., Lowenberg, B., Leopold, L., Munteanu, M., Eten, C. and Berger, M. 2001. Preliminary report of the safety and efficacy of gemtuzumab ozogamicin (Mylotarg (R)) given in combination with cytarabine and daunorubicin in patients with acute myeloid leukemia. Blood 98 (11) , 199B-199B.

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General)
Additional Information:	Part 2, Meeting abstract 4500
Publisher:	American Society of Hematology
ISSN:	0006-4971
Last Modified:	25 Jun 2017 04:45
URI:	https://orca.cardiff.ac.uk/id/eprint/60204

Actions (repository staff only)

Edit Item